KMT2A and acute lymphoblastic leukemia: In the present study, we employed a focused CRISPR-Cas9-based screen targeting well-characterized genes associated with epigenetic and epitranscriptomic modifications in B-ALL models driven by MLL-r and BCR-ABL.